Home/Filings/4/0001140361-16-069921
4//SEC Filing

CYTORI THERAPEUTICS, INC. 4

Accession 0001140361-16-069921

$PSTVCIK 0001095981operating

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 7:09 PM ET

Size

16.3 KB

Accession

0001140361-16-069921

Insider Transaction Report

Form 4
Period: 2016-06-15
RICKEY DAVID
Director
Transactions
  • Exercise of In-Money

    Subscription Rights (Right to Buy)

    2016-06-156,0000 total(indirect: By Trust)
    Exercise: $2.55From: 2016-05-26Exp: 2016-06-10See Footnote (6,000 underlying)
  • Exercise of In-Money

    Common Stock

    2016-06-15+6,00024,004 total(indirect: By Trust)
  • Exercise of In-Money

    Subscription Rights (Righ to Buy)

    2016-06-1516,0000 total(indirect: By Trust)
    Exercise: $2.55From: 2016-05-26Exp: 2016-06-10See Footnote (16,000 underlying)
  • Exercise of In-Money

    Common Stock

    2016-06-15+16,00071,226 total(indirect: By Trust)
  • Exercise of In-Money

    Warrants (Right to Buy)

    2016-06-15+3,0003,000 total(indirect: By Trust)
    Exercise: $3.06From: 2016-06-15Exp: 2018-12-14Common Stock (3,000 underlying)
  • Exercise of In-Money

    Warrants (Right to Buy)

    2016-06-15+8,0008,000 total(indirect: By Trust)
    Exercise: $3.06From: 2016-06-15Exp: 2018-12-14Common Stock (8,000 underlying)
Footnotes (4)
  • [F1]These securities are owned by the Dave Rickey and Daughters Foundation Charitable Trust.
  • [F2]These securities are owned by The David M Rickey Trust u/a DTD 5/8/2002, David M. Rickey Trustee.
  • [F3]The common stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, Inc. (the "Company) to all holders of the Company's common stock. The subscription rights entitled each recipient thereof to purchase units ("Units"). Each Unit consists of one share of the Company's common stock and 0.5 of a warrant, with each warrant representing the right to purchase one share of the Company's common stock. The purchase price for each Unit was $2.55
  • [F4]Each warrant entitles the holder to purchase one share of the Company's common stock at an exercise price of $3.06 from the date of issuance through December 14, 2018.

Documents

1 file

Issuer

CYTORI THERAPEUTICS, INC.

CIK 0001095981

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001095981

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 7:09 PM ET
Size
16.3 KB